These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34926633)

  • 1. CAvant® WO-60 as an Effective Immunological Adjuvant for Avian Influenza and Newcastle Disease Vaccine.
    Lee ES; Shim YJ; Chathuranga WAG; Ahn YH; Yoon IJ; Yoo SS; Lee JS
    Front Vet Sci; 2021; 8():730700. PubMed ID: 34926633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative safety and efficacy of two bivalent vaccines containing Newcastle disease LaSota and avian influenza H9N2 Sidrap isolate formulated with different oil adjuvants.
    Cahyani JI; Widyarini S; Wibowo MH
    Vet World; 2020 Nov; 13(11):2493-2501. PubMed ID: 33363346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza.
    Zhao J; Yang H; Xu H; Ma Z; Zhang G
    Virol J; 2017 Mar; 14(1):56. PubMed ID: 28302119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation and Comparison of the Potential Immunogenicity of Two Commercial Inactivated Bivalent Newcastle and Avian Influenza Vaccines in SPF Chicken.
    Mehrabanpour M
    Arch Razi Inst; 2019 Sep; 74(3):251-257. PubMed ID: 31592590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Potential Adjuvanticity of CAvant
    Ahn YH; Chathuranga WAG; Shim YJ; Haluwana DK; Kim EH; Yoon IJ; Lim YT; Shin SH; Jo H; Hwang SY; Kim HM; Lee MJ; Park JH; Yoo SS; Lee JS
    Vaccines (Basel); 2021 Sep; 9(10):. PubMed ID: 34696199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Bivalent Inactivated Vaccine Containing Insect Cell-Expressed Avian Influenza H5 and Egg-Based Newcastle Disease Virus (NDV) Against Dual Infection with Highly Pathogenic H5N1 and Velogenic NDV in Chickens.
    Said M; Soliman MA; Mousa S; Arafa A; Hussein HA; Amarin N; Mundt E
    Avian Dis; 2019 Sep; 63(3):474-480. PubMed ID: 31967431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of single dose of a bivalent vaccine containing inactivated Newcastle disease virus and reassortant highly pathogenic avian influenza H5N1 virus against lethal HPAI and NDV infection in chickens.
    Lee DH; Park JK; Kwon JH; Yuk SS; Erdene-Ochir TO; Jang YH; Seong BL; Lee JB; Park SY; Choi IS; Song CS
    PLoS One; 2013; 8(3):e58186. PubMed ID: 23469269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-thermal plasma for inactivated-vaccine preparation.
    Wang G; Zhu R; Yang L; Wang K; Zhang Q; Su X; Yang B; Zhang J; Fang J
    Vaccine; 2016 Feb; 34(8):1126-32. PubMed ID: 26529075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric Newcastle Disease Virus-like Particles Containing DC-Binding Peptide-Fused Haemagglutinin Protect Chickens from Virulent Newcastle Disease Virus and H9N2 Avian Influenza Virus Challenge.
    Xu X; Qian J; Qin L; Li J; Xue C; Ding J; Wang W; Ding W; Yin R; Jin N; Ding Z
    Virol Sin; 2020 Aug; 35(4):455-467. PubMed ID: 32274680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective efficacy of combined trivalent inactivated ISA 71 oil adjuvant vaccine against avian influenza virus subtypes (H9N2 and H5N1) and Newcastle disease virus.
    Ali ZM; Hassan MAEM; Hussein HA; Ahmed BM; Sanousi AAEE
    Vet World; 2017 Oct; 10(10):1212-1220. PubMed ID: 29184367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel recombinant attenuated Newcastle disease virus expressing H9 subtype hemagglutinin protected chickens from challenge by genotype VII virulent Newcastle disease virus and H9N2 avian influenza virus.
    Xu X; Xue C; Liu X; Li J; Fei Y; Liu Z; Mu J; Bi Y; Qian J; Yin R; Ding Z
    Vet Microbiol; 2019 Jan; 228():173-180. PubMed ID: 30593364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective dose of a recombinant Newcastle disease LaSota-avian influenza virus H5 vaccine against H5N2 highly pathogenic avian influenza virus and velogenic viscerotropic Newcastle disease virus in broilers with high maternal antibody levels.
    Sarfati-Mizrahi D; Lozano-Dubernard B; Soto-Priante E; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M
    Avian Dis; 2010 Mar; 54(1 Suppl):239-41. PubMed ID: 20521638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing immunogenicity and protective efficacy of inactivated avian influenza H9N2vaccine with recombinant chicken IFN-α in chicken.
    Gan L; Tian Y; Zhao Y; Shan XQ; Zhou W; Xia BB; Chen J; Wang ML; Zhao J
    Vet Microbiol; 2019 Jul; 234():77-82. PubMed ID: 31213275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
    Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of an inactivated avian influenza virus vaccine adjuvanted with poly(D,L-lactic-co-glycolic acid) encapsulated CpG ODN induces protective immune responses in chickens.
    Singh SM; Alkie TN; Nagy É; Kulkarni RR; Hodgins DC; Sharif S
    Vaccine; 2016 Sep; 34(40):4807-13. PubMed ID: 27543454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and evaluation of a Newcastle disease virus-based H9 avian influenza live vaccine.
    Ge J; Tian G; Zeng X; Jiang Y; Chen H; Bua Z
    Avian Dis; 2010 Mar; 54(1 Suppl):294-6. PubMed ID: 20521648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Effectiveness of Two Oil Adjuvant-Inactivated Avian Influenza H9N2 Vaccines.
    Kilany WH; Bazid AH; Ali A; El-Deeb AH; El-Abideen MA; Sayed ME; El-Kady MF
    Avian Dis; 2016 May; 60(1 Suppl):226-31. PubMed ID: 27309059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparison of Toll-Like Receptor 5 and 21 Ligands as Adjuvants for a Formaldehyde Inactivated H9N2 Avian Influenza Virus Vaccine in Chickens.
    Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Shojadoost B; Petrik JJ; Nagy É; Sharif S
    Viral Immunol; 2018 Nov; 31(9):605-612. PubMed ID: 30222508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quick and improved immune responses to inactivated H9N2 avian influenza vaccine by purified active fraction of Albizia julibrissin saponins.
    Sun H; Fei L; Zhu B; Shi M
    BMC Vet Res; 2020 Nov; 16(1):427. PubMed ID: 33160337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic evaluation of 10 different adjuvants for use in vaccines for chickens against highly pathogenic avian influenza virus.
    Lone NA; Spackman E; Kapczynski D
    Vaccine; 2017 Jun; 35(26):3401-3408. PubMed ID: 28511853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.